We are accelerating the pace of cancer research
by accruing patients to clinical trials, allowing
more patients to have access to new molecules and
therapies. We are bringing state-of-the-art diagnostic
and treatment technologies to local towns and cities.
We are leveraging economies-of-scale to reduce health-care
costs. And we are working with patient advocacy groups
to drive public-policy efforts.
Putting it
simply, we are a strong force in the war on cancer,
employing our nationwide resources to fight cancer
in every way possible. In doing so, we are driving
an innovative new services model and helping oncologists
deliver the best possible care.
